Free Trial
OTCMKTS:INNV

InnovAge (INNV) Stock Price, News & Analysis

InnovAge logo
$5.18 +0.20 (+4.02%)
As of 04:00 PM Eastern

About InnovAge Stock (OTCMKTS:INNV)

Advanced

Key Stats

Today's Range
$4.81
$5.23
50-Day Range
$3.13
$5.18
52-Week Range
$2.60
$6.69
Volume
53,906 shs
Average Volume
45,703 shs
Market Capitalization
$702.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

INNV Stock News Headlines

Crypto Gets Official Government Backing—Here's the Winner
Trump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really investing in this coin.tc pixel
InnovAge Earns Recertification as a Great Place to Work
InnovAge to reinforce senior care program PACE
See More Headlines

INNV Stock Analysis - Frequently Asked Questions

InnovAge's stock was trading at $3.93 at the start of the year. Since then, INNV stock has increased by 31.8% and is now trading at $5.18.

InnovAge Holding Corp. (OTCMKTS:INNV) posted its quarterly earnings data on Tuesday, November, 9th. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.05 by $0.01. The company earned $173.07 million during the quarter, compared to analyst estimates of $173.13 million. InnovAge had a negative trailing twelve-month return on equity of 13.04% and a negative net margin of 6.17%.

Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that InnovAge investors own include EEStor Co. (ESU.V) (ESU), Antares Pharma (ATRS), Medicines (MDCO), Fannie Mae (FNMA), Frontier Communications (FTR), FedEx (FDX) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/09/2021
Today
9/16/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Medical Care Facilities
Sub-Industry
Healthcare
Current Symbol
OTCMKTS:INNV
Previous Symbol
NASDAQ:INNV
CIK
1411879
Fax
N/A
Employees
2,000
Year Founded
1990

Profitability

EPS (Trailing Twelve Months)
($0.23)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.52 million
Net Margins
-6.17%
Pretax Margin
-7.63%
Return on Equity
-13.04%
Return on Assets
-7.48%

Debt

Debt-to-Equity Ratio
0.25
Current Ratio
1.57
Quick Ratio
1.57

Sales & Book Value

Annual Sales
$853.70 million
Price / Sales
0.82
Cash Flow
$0.08 per share
Price / Cash Flow
65.41
Book Value
$2.50 per share
Price / Book
2.07

Miscellaneous

Outstanding Shares
135,638,000
Free Float
135,311,000
Market Cap
$702.60 million
Optionable
Not Optionable
Beta
0.52

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (OTCMKTS:INNV) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners